Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

American Shared Hospital Services third quarter revenue increases to $9,148,000

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, today announced financial results for the third quarter and first nine months of 2011.

From Elekta 14 Nov 2011

First large scale trial of acupuncture for prevention of xerostomia

When given alongside radiation therapy for head and neck cancer, acupuncture has shown for the first time to reduce the debilitating side effect of xerostomia, according to new research from The University of Texas MD Anderson Cancer Center and Fudan University Shanghai Cancer Center.

11 Nov 2011

U of T, UHN launch Techna Institute to develop new healthcare technologies

The Techna Institute, an innovation hub poised to integrate and fast track research, development and commercialization of new healthcare technologies, launches today at University Health Network (UHN) and the University of Toronto.

10 Nov 2011

Alliance HealthCare Services third quarter revenue increases 4.7% to $126.8 million

Alliance HealthCare Services, Inc., a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced results for the third quarter ended September 30, 2011.

9 Nov 2011

Accuray reports total consolidated GAAP revenue of $100.5 million for first quarter 2012

Accuray Incorporated, the premier radiation oncology company, announced today financial results for the first quarter of fiscal 2012 that ended September 30, 2011.

9 Nov 2011

Teaching hospitals might provide better radical prostatectomy results

Prostate cancer patients who undergo radical prostatectomy get better results at teaching hospitals than at non-academic medical institutions, according to the findings of an international study led by researchers at Henry Ford Hospital.

8 Nov 2011

New technology can detect toxins in a person's breath

Breathing. Anyone reading this article is doing it right now. But what chemicals are we breathing in, and out? A group of Virginia Tech College of Engineering researchers has published a paper in the journal Environmental Science & Technology that details how to learn just that, using microelectromechanical systems to focus on toxins and everyday impurities that enter the body through the air we intake.

8 Nov 2011

Bristol-Myers Squibb receives FDA approval for Erbitux to treat head and neck cancer

The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.

8 Nov 2011

AMS pleased with CMS' increase in 2012 payment rate for proton therapy

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, said today that the recent announcement by the Centers for Medicare & Medicade Services (CMS) of a 15% increase in the payment rate of proton therapy for hospital based centers beginning in 2012 strengthens the economic case for the proton centers now under development by the Company.

7 Nov 2011

Chemotherapy plus radiation improves overall survival for patients with stage II NPC

The combination of chemotherapy and radiation significantly improved the 5-year overall survival of patients with stage II nasopharyngeal carcinoma (NPC), according to a phase III study published Nov. 4 in the Journal of the National Cancer Institute.

5 Nov 2011

Benefits of combined therapy for men with high-risk prostate cancer

Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research led by radiation oncologists at the Princess Margaret Hospital (PMH) Cancer Program, University Health Network.

3 Nov 2011

Radiation therapy prior to HCT improves outcomes in older patients with hematologic malignancies

Older patients with advanced hematologic malignancies, such as leukemia and lymphoma, who received a conditioning regimen that included minimal-intensity radiation therapy prior to allogeneic hematopoietic cell transplantation had survival and progression-free survival outcomes suggesting that this treatment approach may be a viable option for older patients with these malignancies, according to a study in the November 2 issue of JAMA.

2 Nov 2011

iCAD, Hitachi enter distribution agreement for MRI breast cancer diagnosis and guided biopsy solution

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, today announced that it has entered into a distribution agreement with Hitachi Medical Systems.

31 Oct 2011

'Heroes of Hope Race for Brain Tumor Research' event to be held on Nov. 6

Veronica Cappalonga, 28, knows a lot about living with cancer. Diagnosed at age 6 with leukemia and at 22 with a malignant brain tumor, the Los Angeles (Mar Vista area) resident will walk in the Nov. 6 Heroes of Hope Race for Brain Tumor Research - not only to help fundraise, but also to show that survivors can fight these diseases with dignity.

29 Oct 2011

Varian to supply TrueBeam treatment systems to Lund University Hospital

Varian Medical Systems has been awarded a contract to supply four TrueBeam treatment systems to Lund University Hospital in Sweden, one of the country's largest radiotherapy departments. The order, confirmed in September, is aimed at cutting treatment waiting lists in the Skane region of Sweden and includes an option to acquire two further TrueBeam systems in 2014.

28 Oct 2011

Carl Zeiss Meditec to showcase new clinical and productivity tools at AAO annual meeting

Carl Zeiss Meditec will showcase new clinical and productivity tools across the glaucoma, retina, cataract and refractive workplaces during this week's American Academy of Ophthalmology Annual Meeting in Orlando at booth #821.

24 Oct 2011

EAE, ASE to issue echocardiography guidelines for early detection of cardio toxicity

"Considering that the early detection of cardio toxicity is a critical issue for patients undergoing chemotherapy, the ASE and the EAE have come together to write guidelines which will highlight the technical advantages of echocardiography in identifying cardio toxicity early," explained Prof Juan Carlos Plana, Co-Director of the Cardio-oncology Center, Cleveland Clinic, from the ASE. "

21 Oct 2011

OncoGenex commences enrollment in OGX-427 Phase II trial for bladder cancer

OncoGenex Pharmaceuticals, Inc. announced today that it has initiated patient enrollment in a randomized, Phase II clinical trial evaluating OGX-427, an inhibitor of heat shock protein 27 (Hsp27), in patients with advanced bladder cancer.

21 Oct 2011

Mathematical optimization models to improve radiation therapy for cancer

Engineering researchers at the University of Arkansas have developed mathematical optimization models that will make radiation treatment plans safer and more efficient than conventional plans.

From Elekta 14 Oct 2011

RAZCER (Rapid Astrazeneca and CARO Evaluation of Radio-modifiers) awards announced - five Canadians win

Five leading Canadian radiation oncologists receive RAZCER Awards of $22,727 each for novel studies of radiation-drug interactions that have the potential to either protect normal tissues or sensitize tumours, and thus to enhance the effectiveness of radiation therapy for cancer patients. A selection committee of members of the Canadian Association of Radiation Oncology (CARO) selected the 2011 recipients from among a field of 12 applicants. Astrazeneca provides the funds for the RAZCER Award as an educational grant.

13 Oct 2011

Radiation Therapy News and Research

Further Reading

American Shared Hospital Services third quarter revenue increases to $9,148,000

First large scale trial of acupuncture for prevention of xerostomia

U of T, UHN launch Techna Institute to develop new healthcare technologies

Alliance HealthCare Services third quarter revenue increases 4.7% to $126.8 million

Accuray reports total consolidated GAAP revenue of $100.5 million for first quarter 2012

Teaching hospitals might provide better radical prostatectomy results

New technology can detect toxins in a person's breath

Bristol-Myers Squibb receives FDA approval for Erbitux to treat head and neck cancer

AMS pleased with CMS' increase in 2012 payment rate for proton therapy

Chemotherapy plus radiation improves overall survival for patients with stage II NPC

Benefits of combined therapy for men with high-risk prostate cancer

Radiation therapy prior to HCT improves outcomes in older patients with hematologic malignancies

iCAD, Hitachi enter distribution agreement for MRI breast cancer diagnosis and guided biopsy solution

'Heroes of Hope Race for Brain Tumor Research' event to be held on Nov. 6

Varian to supply TrueBeam treatment systems to Lund University Hospital

Carl Zeiss Meditec to showcase new clinical and productivity tools at AAO annual meeting

EAE, ASE to issue echocardiography guidelines for early detection of cardio toxicity

OncoGenex commences enrollment in OGX-427 Phase II trial for bladder cancer

Mathematical optimization models to improve radiation therapy for cancer

RAZCER (Rapid Astrazeneca and CARO Evaluation of Radio-modifiers) awards announced - five Canadians win

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News